Roden, D. M., Van Driest, S. L., Mosley, J. D., Wells, Q. S., Robinson, J. R., Denny, J. C., & Peterson, J. F. (2018). Benefit of pre-emptive pharmacogenetic information on clinical outcome. Clin Pharmacol Ther.
Chicago Style CitationRoden, Dan M., Sara L. Van Driest, Jonathan D. Mosley, Quinn S. Wells, Jamie R. Robinson, Joshua C. Denny, i Josh F. Peterson. "Benefit of Pre-emptive Pharmacogenetic Information On Clinical Outcome." Clin Pharmacol Ther 2018.
Cita MLARoden, Dan M., et al. "Benefit of Pre-emptive Pharmacogenetic Information On Clinical Outcome." Clin Pharmacol Ther 2018.
Atenció: Aquestes cites poden no estar 100% correctes.